CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 266 filers reported holding CYTOKINETICS INC in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,427,789 | +10.7% | 320,020 | +22.6% | 0.00% | 0.0% |
| Q2 2023 | $8,513,136 | -79.9% | 260,979 | -78.3% | 0.00% | -75.0% |
| Q1 2023 | $42,342,543 | +164.7% | 1,203,255 | +244.6% | 0.00% | +100.0% |
| Q4 2022 | $15,998,236 | +25.1% | 349,154 | +32.3% | 0.00% | 0.0% |
| Q3 2022 | $12,789,000 | +11.7% | 263,939 | -9.4% | 0.00% | +100.0% |
| Q2 2022 | $11,453,000 | -25.8% | 291,476 | -30.5% | 0.00% | 0.0% |
| Q1 2022 | $15,430,000 | +14.9% | 419,157 | +42.2% | 0.00% | 0.0% |
| Q4 2021 | $13,433,000 | +62.3% | 294,733 | +27.2% | 0.00% | 0.0% |
| Q3 2021 | $8,279,000 | +70.5% | 231,639 | -5.6% | 0.00% | 0.0% |
| Q2 2021 | $4,857,000 | +40.4% | 245,402 | +65.0% | 0.00% | – |
| Q1 2021 | $3,460,000 | +22.4% | 148,753 | +9.3% | 0.00% | – |
| Q4 2020 | $2,826,000 | -53.5% | 136,058 | -51.5% | 0.00% | -100.0% |
| Q3 2020 | $6,080,000 | +38.5% | 280,816 | +50.8% | 0.00% | 0.0% |
| Q2 2020 | $4,390,000 | +520.1% | 186,279 | +210.5% | 0.00% | – |
| Q1 2020 | $708,000 | +105.2% | 59,995 | +84.7% | 0.00% | – |
| Q4 2019 | $345,000 | -27.2% | 32,487 | -22.0% | 0.00% | – |
| Q3 2019 | $474,000 | -42.8% | 41,660 | -43.4% | 0.00% | – |
| Q2 2019 | $828,000 | +53.6% | 73,606 | +10.6% | 0.00% | – |
| Q1 2019 | $539,000 | +96.0% | 66,576 | +53.2% | 0.00% | – |
| Q4 2018 | $275,000 | +159.4% | 43,462 | +303.8% | 0.00% | – |
| Q3 2018 | $106,000 | -54.3% | 10,763 | -61.6% | 0.00% | – |
| Q2 2018 | $232,000 | -25.2% | 28,057 | -34.8% | 0.00% | – |
| Q1 2018 | $310,000 | -14.4% | 43,050 | -3.1% | 0.00% | – |
| Q4 2017 | $362,000 | -67.7% | 44,448 | -42.4% | 0.00% | – |
| Q3 2017 | $1,120,000 | +6.1% | 77,178 | -11.6% | 0.00% | – |
| Q2 2017 | $1,056,000 | +551.9% | 87,311 | +594.5% | 0.00% | – |
| Q1 2017 | $162,000 | +45.9% | 12,571 | +36.8% | 0.00% | – |
| Q4 2016 | $111,000 | +131.2% | 9,188 | +76.0% | 0.00% | – |
| Q3 2016 | $48,000 | +20.0% | 5,219 | +23.8% | 0.00% | – |
| Q2 2016 | $40,000 | +400.0% | 4,214 | +275.9% | 0.00% | – |
| Q1 2016 | $8,000 | -63.6% | 1,121 | -46.1% | 0.00% | – |
| Q4 2015 | $22,000 | +175.0% | 2,081 | +67.4% | 0.00% | – |
| Q3 2015 | $8,000 | +300.0% | 1,243 | +294.6% | 0.00% | – |
| Q2 2015 | $2,000 | +100.0% | 315 | +133.3% | 0.00% | – |
| Q1 2015 | $1,000 | -98.3% | 135 | -98.2% | 0.00% | – |
| Q4 2014 | $60,000 | +150.0% | 7,543 | +8.7% | 0.00% | – |
| Q3 2014 | $24,000 | -79.8% | 6,940 | -72.0% | 0.00% | – |
| Q2 2014 | $119,000 | -17.4% | 24,811 | +63.7% | 0.00% | – |
| Q1 2014 | $144,000 | +10.8% | 15,154 | -24.3% | 0.00% | – |
| Q4 2013 | $130,000 | -48.0% | 20,013 | -39.3% | 0.00% | – |
| Q3 2013 | $250,000 | – | 32,988 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |